Cisatracurium Besylate Injection
Product Images NDC 70710-1532

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cisatracurium Besylate (NDC 70710-1532). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

226b466f B4db 491d 987d 55a811889f26 01

Chemical structure diagram of cisatracurium besylate showing its molecular arrangement, including two aromatic rings, nitrogen atoms with positive charges, ester linkages, and the besylate counterion depicted between the two cisatracurium molecules.*

FDA Label Image

226b466f B4db 491d 987d 55a811889f26 02

A scatter plot chart depicting individual data points with percentage changes on two axes: mean arterial pressure (MAP) on the horizontal axis and heart rate (HR) on the vertical axis, both ranging from -60% to +60%. The data points are clustered near the center, indicating variation around zero change for these cardiovascular metrics.*

FDA Label Image

226b466f B4db 491d 987d 55a811889f26 03

A scatter plot graph illustrating percent changes in heart rate (HR) on the vertical axis and mean arterial pressure (MAP) on the horizontal axis, both ranging from -60% to +60%. Data points are distributed around the origin, indicating various measured responses.*

FDA Label Image

226b466f B4db 491d 987d 55a811889f26 04

Label for Cisatracurium Besylate Injection, USP 10 mg/5 mL (2 mg/mL) by Zydus Pharmaceuticals USA Inc. The label indicates a 5 mL single-dose vial for intravenous injection, preservative-free, with storage instructions at 2°C to 8°C. It includes a warning that the product is a paralyzing agent causing respiratory arrest and requires facilities for artificial respiration.*

FDA Label Image

226b466f B4db 491d 987d 55a811889f26 05

Label for cisatracurium besylate injection, USP, 10 mg/mL strength, in a 20 mL single-dose vial. The label indicates a total of 200 mg per 20 mL. The product is distributed by Zydus Pharmaceuticals USA Inc. It is a sterile, nonpyrogenic solution for intravenous injection. The label contains warnings about its paralytic effects and the need for artificial respiration support, and storage instructions to keep refrigerated at 2°C to 8°C.*

FDA Label Image

226b466f B4db 491d 987d 55a811889f26 06

Packaging label for Cisatracurium Besylate Injection, USP 10 mg/5 mL (2 mg/mL) single-dose vials. The label shows the product name, strength, intravenous injection usage, preserverative-free status, and a warning indicating it as a paralyzing agent. The labeler is Zydus Pharmaceuticals USA Inc., with 10 vials of 5 mL each per package. The barcode and manufacturer details are visible on the label.*

FDA Label Image

226b466f B4db 491d 987d 55a811889f26 07

Packaging label for Cisatracurium Besylate Injection, USP, 200 mg/20 mL (10 mg/mL) intravenous injection by Zydus Pharmaceuticals USA Inc. The label indicates 10 single-dose 20 mL vials, preservative free, with warnings including use for ICU only and paralyzing agent. The label features purple and red text accents and includes storage and usage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.